SCHEMBL175885

SCHEMBL175885

COc1cc(-c2c(C3CCNC3)c(C3CCCC3)n3ncnc(Nc4ccccc4)c23)ccc1Oc1cccc(Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 2/20 0.47
TNK2 Q07912 6/20 0.42
EGFR P00533 8/20 0.38
EPHA2 P29317 1/20 0.36
ERBB2 P04626 4/20 0.36
ERBB3 P21860 3/20 0.36
ERBB4 Q15303 3/20 0.36
HTR1A P08908 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
KDM4E B2RXH2 2/20 0.34
MAPT P10636 2/20 0.34
MAPK1 P28482 2/20 0.34
MEN1 O00255 1/20 0.34
GMNN O75496 1/20 0.34
ALDH1A1 P00352 1/20 0.34
ABL1 P00519 1/20 0.34
LMNA P02545 1/20 0.34
RAF1 P04049 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL122915 0.88 BTK (0.60) BTKTNK2HTR1ASLC6A2SLC6A4
SCHEMBL122300 0.83 BTK (0.61) BTKTNK2HTR1ASLC6A2SLC6A4
SCHEMBL167539 0.83 BTK (0.61) BTKTNK2HTR1ASLC6A2SLC6A4
SCHEMBL175374 0.76 BTK (0.69) BTKTNK2HTR2CHTR2B
SCHEMBL170027 0.76 BTK (0.61) BTKTNK2
SCHEMBL123477 0.75 BTK (0.56) BTKTNK2HTR1ASLC6A2SLC6A4
SCHEMBL169823 0.74 BTK (0.61) BTKTNK2
SCHEMBL168773 0.74 TNK2 (0.50) BTKTNK2
SCHEMBL122913 0.73 BTK (0.60) BTKTNK2
SCHEMBL121733 0.72 BTK (0.54) BTKTNK2HTR1ASLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424368-A1 PYRROLOTRIAZINE COMPOUNDS Locus Pharmaceuticals, Inc. (US) 2012-03-07 EP disclosed
WO-2010126960-A1 PYRROLOTRIAZINE COMPOUNDS LOCUS PHARMACEUTICALS, INC. (US) 2010-11-04 WO disclosed